Hemophilia A
MONDO:0010602The most common form of hemophilia characterized by spontaneous or prolonged hemorrhages due to factor VIII deficiency.
Also known as: congenital factor VIII disorder, factor VIII deficiency, haemophilia a, X-linked recessive, haemophilia type A, haemophilia type a, hemophilia A, hemophilia a, X-linked recessive, hemophilia type A
183 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
Can a clotting boost make surgery safer for hemophilia patients?
Disease control TerminatedThis trial tests whether a medication called eptacog beta can safely prevent excessive bleeding in people with hemophilia A or B who have inhibitors and need major surgery. Participants receive the drug during and after their operation, and doctors measure how well bleeding is co…
Phase: PHASE3 • Sponsor: Laboratoire français de Fractionnement et de Biotechnologies • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Hemophilia drug study falls short: only 3 patients enrolled before termination
Disease control TerminatedThis study aimed to see if a new medicine (efanesoctocog alfa) helps people with moderate or severe hemophilia A reach their personal goals and be more physically active. It planned to enroll 35 people aged 12 to 50, but was stopped early after only 3 joined. The medicine is used…
Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Could home blood tests transform hemophilia care? study seeks patient views
Knowledge-focused TerminatedThis study looked at how patients with hemophilia A or those on blood thinners feel about monitoring their blood clotting at home. Researchers interviewed 19 people to understand their needs and hopes for a new device that could measure clotting factors. The goal was to gather in…
Sponsor: Radboud University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC